4th Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for NEUROMOLECULAR PHARMACEUTICALS
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues relating to pandemic influenza and government preparedness
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUDY BLACK | — |
| DAVID PHILLIP COHEN | — |
| TERESA DYER | — |
| C SUZANNE MENCER | — |
| KATIE STAHL | Legislative Intern - Senator Orrin Hatch |
Disaster Planning/Emergencies DIS
Issues relating to pandemic influenza and government preparedness
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUDY BLACK | — |
| DAVID PHILLIP COHEN | — |
| TERESA DYER | — |
| C SUZANNE MENCER | — |
| KATIE STAHL | Legislative Intern - Senator Orrin Hatch |
Pharmacy PHA
Issues relating to pandemic influenza and governmental preparedness
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUDY BLACK | — |
| DAVID PHILLIP COHEN | — |
| TERESA DYER | — |
| C SUZANNE MENCER | — |
| KATIE STAHL | Legislative Intern - Senator Orrin Hatch |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.